Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
11/01/2012 | US20120277161 Inhibition of multiple cell activation pathways |
11/01/2012 | US20120277153 Treating liver diseases |
11/01/2012 | US20120277143 IL4/IL13 Binding Repeat Proteins and Uses |
11/01/2012 | US20120277120 Methods for genomic modification |
11/01/2012 | US20120277111 MicroRNA Mediated Neuronal Cell Induction |
11/01/2012 | US20120276636 Method for improving induced pluripotent stem cell generation efficiency |
11/01/2012 | US20120276634 somatic embryogenesis and embryo harvesting and method and apparatus for preparing plant embryos for plant production |
11/01/2012 | US20120276633 Supplying treated exhaust gases for effecting growth of phototrophic biomass |
11/01/2012 | US20120276632 Plasma-free platelet lysate for use as a supplement in cell cultures and for the preparation of cell therapeutics |
11/01/2012 | US20120276631 Methods for controlling the galactosylation profile of recombinantly-expressed proteins |
11/01/2012 | US20120276630 Dry powder cells and cell culture reagents and methods of production thereof |
11/01/2012 | US20120276629 Methods for isolating stem cells |
11/01/2012 | US20120276628 Automated systems and methods for isolating regenerative cells from adipose tissue |
11/01/2012 | US20120276627 Synthetic mimics of mir-124 |
11/01/2012 | US20120276626 Synthetic surfaces for culturing stem cell derived cardiomyocytes |
11/01/2012 | US20120276625 Method for producing mesenchymal stem cells from human pluripotent stem cells, and mesenchymal stem cells produced by same |
11/01/2012 | US20120276624 Methods for identifying factors for differentiating definitive endoderm |
11/01/2012 | US20120276611 Recombinantly modified plasmin |
11/01/2012 | US20120276591 Compositions and Methods for Use for Antibodies Against Sclerostin |
11/01/2012 | US20120276581 Method for preserving cancellous bone samples and preserved cancellous bone tissue |
11/01/2012 | US20120276579 Organic compounds |
11/01/2012 | US20120276573 Nanotube structures, methods of making nanotube structures, and methods of accessing intracellular space |
11/01/2012 | US20120276572 Methods and compositions for identifying and validating modulators of cell fate |
11/01/2012 | US20120276556 Ligating BDCA-2 Protein for the Purpose of Isolating or Modulating Dendritic Cells |
11/01/2012 | US20120276554 Isolation and use of ryanodine receptors |
11/01/2012 | US20120276553 Mesenchymal precursor cell |
11/01/2012 | US20120276548 Multimer glycosylated nucleic acid binding protein conjugates and uses thereof |
11/01/2012 | US20120276215 Therapeutic Conditioned Media |
11/01/2012 | US20120276209 Nucleic acid-containing lipid particles and related methods |
11/01/2012 | US20120276203 Collagen matrix for cell therapy |
11/01/2012 | US20120276192 Compositions and methods for sirna inhibition of icam-1 |
11/01/2012 | US20120276190 Therapy with a chimeric molecule and a pro-apoptotic agent |
11/01/2012 | US20120276171 Micelle encapsulation of therapeutic agents |
11/01/2012 | US20120276155 Tolerogenic synthetic nanocarriers for generating cd8+ regulatory t cells |
11/01/2012 | US20120276147 Ctsp cancer-testis antigens |
11/01/2012 | US20120276133 Tolerogenic synthetic nanocarriers for inducing regulatory b cells |
11/01/2012 | US20120276131 Anti-trypanosomiasis vaccines and diagnostics |
11/01/2012 | US20120276128 HIV Envelope-CD4 Complexes and Hybrids |
11/01/2012 | US20120276125 Novel immunoconjugates |
11/01/2012 | US20120276119 CD37-Binding Molecules and Immunoconjugates Thereof |
11/01/2012 | US20120276112 Anti-factor xi monoclonal antibodies and methods of use thereof |
11/01/2012 | US20120276091 Human Recombinant Monoclonal Antibody That Specifically Binds to VCAM-1 and Inhibits Adhesion and Transmigration Between Leukocytes and Endothelial Cells |
11/01/2012 | US20120276086 Monoclonal antibodies against cd30 lacking in fucosyl and xylosyl residues |
11/01/2012 | US20120276079 Method of producing recombinant vitamin k dependent proteins |
11/01/2012 | US20120276078 Glycosidase enzymes |
11/01/2012 | US20120276076 Arf6 as a new target for treating alzheimer's disease |
11/01/2012 | US20120276073 Treatment of nerve injuries |
11/01/2012 | US20120276072 Constructs for expressing lysosomal polypeptides |
11/01/2012 | US20120276070 Induced Pluripotent Stem Cells and Related Methods |
11/01/2012 | US20120276066 Peptide Linked Cell Matrix Materials for Stem Cells and Methods of Using the Same |
11/01/2012 | US20120276065 Dendritic Cell Populations that are Enriched for Cells that Bear the BDCA-1 Antigen |
11/01/2012 | US20120276063 Priming of pluripotent stem cells for neural differentiation |
11/01/2012 | US20120276052 Transgene delivering retrovirus targeting collagen exposed at site of tissue injury |
11/01/2012 | US20120276046 Anti ganglioside gd3 antibodies and uses thereof |
11/01/2012 | US20120276013 Genetically determined mouse model of resistance to transplantable cancers |
11/01/2012 | US20120276012 Method of Treatment and Screening Method |
11/01/2012 | US20120276011 Nanoparticulate probe for in vivo monitoring of tissue oxygenation |
11/01/2012 | US20120276009 Pharmaceutical composition |
11/01/2012 | US20120276004 Human myeloid derived suppressor cell cancer markers |
11/01/2012 | US20120275999 Oncolytic rhabdovirus |
11/01/2012 | US20120275997 Chimeric antibodies specific for cd151 and use thereof in the treatment of cancer |
11/01/2012 | US20120275996 IL-1 Binding Proteins |
11/01/2012 | CA2834624A1 Il4/il13 binding repeat proteins and uses |
11/01/2012 | CA2834279A1 Process using exhaust gases for effecting growth of phototrophic biomass |
11/01/2012 | CA2834255A1 Peptide for inducing regeneration of tissue and use thereof |
11/01/2012 | CA2834215A1 Pluripotent stem cell-derived brown adipocytes, pluripotent stem cell-derived cell aggregate, method for producing same, and cell therapy and medical therapy therefor |
11/01/2012 | CA2834207A1 Mirna396 and growth regulating factors for cyst nematode tolerance in plants |
11/01/2012 | CA2834136A1 Anti-b7-h3 antibody |
11/01/2012 | CA2833917A1 Identification of polynucleotides associated with a sample |
11/01/2012 | CA2829974A1 Enhanced transformation of recalcitrant monocots |
10/31/2012 | EP2518152A2 Improved halohydrin epoxidase |
10/31/2012 | EP2518148A1 GENE Dro1 CONTROLLING DEEP-ROOTED CHARACTERISTICS OF PLANT AND UTILIZATION OF SAME |
10/31/2012 | EP2518141A1 Stem cells derived from the carotid body and uses thereof |
10/31/2012 | EP2518140A1 Dedifferentation of adult mammalian cardiomyocytes into cardiac stem cells |
10/31/2012 | EP2518139A1 Use of indirubin derivatives for producing pluripotent stem cells |
10/31/2012 | EP2517555A1 Method for searching and screening for target of anti-cancer agent using non-human animal model having nog established cancer cell line transplanted therein |
10/31/2012 | EP2516653A1 Promoter sequences |
10/31/2012 | EP2516628A1 Treatment of bone fracture |
10/31/2012 | EP2516627A1 Expansion medium for cd34-negative stem cells |
10/31/2012 | EP2516626A2 Differentiation of human embryonic stem cells |
10/31/2012 | EP2516625A2 Differentiation of human embryonic stem cells |
10/31/2012 | EP2516624A1 Cell line 3m |
10/31/2012 | EP2516623A1 Method for culturing adherent cells |
10/31/2012 | EP2516622A2 Enamel matrix derivative-proteins having tissue generating activity |
10/31/2012 | EP2516620A1 Apparatus and method for cell exploitation |
10/31/2012 | EP2516619A1 Device and method for biological sample purification and enrichment |
10/31/2012 | EP2516504A1 Biodegradable polymers, complexes thereof for gene therapeutics and drug delivery, and methods related thereto |
10/31/2012 | EP2515630A2 Genetic markers associated with drought tolerance in maize |
10/31/2012 | DE102011100450A1 Apparatus, useful e.g. for spraying biologically compatible liquids, biologically compatible suspensions, biologically compatible cell suspensions, comprises hollow needle or cannula with hollow pin for separation of liquids or suspensions |
10/31/2012 | CN1461343B 多核苷酸 Polynucleotide |
10/31/2012 | CN102762741A Fluid flow device containing nanotubes and method for cell trafficking using same |
10/31/2012 | CN102762737A Method for manufacturing a pyripyropene |
10/31/2012 | CN102762728A Methods for producing antibody-producing cells that produce desired polypeptides |
10/31/2012 | CN102762720A Subpopulations of spore-like cells and uses thereof |
10/31/2012 | CN102762719A Improved methods of cell culture for adoptive cell therapy |
10/31/2012 | CN102762718A Manipulation of osmolality for differentiating stem cells |
10/31/2012 | CN102762717A Method for constructing chimeric rat using rat embryonic stem cells |
10/31/2012 | CN102762716A Method for optimizing a biopharmaceutical production process |
10/31/2012 | CN102762715A Scaffolds formed from polymer-protein conjugates, methods of generating same and uses thereof |
10/31/2012 | CN102762228A Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors |